Meigs' syndrome with elevated CA-125 and HE-4: a case report and literature review

被引:0
作者
Seong, Jichang [1 ]
Ravshan, Abdusattorov [2 ]
Narkhodzha, Sametdinov [3 ]
Saida, Kurbanova [2 ]
Jamshid, Alimov [2 ,4 ]
Bahriddin, Babanov [5 ]
Biloliddin, Sharobidinov [2 ]
机构
[1] Cent Asian Univ, Sch Med, Tashkent, Uzbekistan
[2] AKFA Medline Univ Hosp, Dept Oncol, Tashkent, Uzbekistan
[3] AKFA Medline Univ Hosp, Dept Gen Surg, Tashkent, Uzbekistan
[4] Republican Specialized Sci & Pract Med Ctr Oncol &, Dept Radiat Oncol, Tashkent, Uzbekistan
[5] Ipsum Pathol, Dept Cytolog & Histol Diagnost, Tashkent, Uzbekistan
关键词
Meigs' syndrome; CA-125; HE-4; fibroma; pleural effusion; ascites; PLEURAL EFFUSION; OVARIAN FIBROMA; CA125; FIBROTHECOMA; HYDROTHORAX; ASCITES; LEVEL; RISK;
D O I
10.3389/fmed.2025.1533388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Meigs' syndrome is a rare gynecological condition characterized by a benign ovarian tumor, ascites, and pleural effusion, all of which resolve spontaneously after tumor removal. While mildly elevated serum CA-125 levels are frequently observed, levels exceeding 1,000 IU/mL are extremely rare, and concurrent elevation of other tumor markers, such as HE-4, may further complicate its diagnosis. We report a case of Meigs' syndrome in a 41-year-old premenopausal woman. Initial presenting symptoms included severe dyspnea, abdominal distention, anorexia, and weight loss. Subsequent imaging studies revealed a large right ovarian tumor accompanied by massive ascites and pleural effusion. Serum CA-125 and HE-4 levels were markedly elevated (1,200 IU/mL and 82.1 pmol/L, respectively), with a Risk of Ovarian Malignancy Algorithm (ROMA) score of 25.63%, suggesting advanced ovarian malignancy. Neoadjuvant chemotherapy was initiated, but the tumor continued to grow, necessitating internal debulking surgery. Postoperative histopathology revealed a benign ovarian fibroma, confirming the diagnosis of Meigs' syndrome. Spontaneous resolution of ascites and pleural effusion occurred by the second postoperative day, and the tumor markers normalized within the next six months. The patient remained disease-free at 2-year follow-up. This case underscores the importance of considering Meigs' syndrome in patients with markedly elevated tumor markers, an ovarian tumor unresponsive to chemotherapy, and concomitant ascites and pleural effusion. Early recognition and surgical intervention are critical for accurate diagnosis and optimal management of this rare condition.
引用
收藏
页数:8
相关论文
共 74 条
[1]  
Mohammed S.A., Kumar A., Cue L., Meigs Syndrome. Statpearls, (2024)
[2]  
Saha S., Robertson M., Meigs' and Pseudo-Meigs' Syndrome, Australas J Ultrasound Med, 15, pp. 29-31, (2012)
[3]  
Meigs J.V., Fibroma of the ovary with ascites and hydrothorax. Meigs' Syndrome, Am J Obstet Gynecol, 67, pp. 962-987, (1954)
[4]  
Krenke R., Maskey-Warzechowska M., Korczynski P., Zielinska-Krawczyk M., Klimiuk J., Chazan R., Et al., Pleural effusion in Meigs' syndrome-transudate or exudate?: systematic review of the literature, Medicine, 94, (2015)
[5]  
Shang W., Wu L., Xu R., Chen X., Yao S., Huang P., Et al., Clinical laboratory features of Meigs' syndrome: a retrospective study from 2009 to 2018, Front Med, 15, pp. 116-124, (2021)
[6]  
Danilos J., Michal Kwasniewski W., Mazurek D., Bednarek W., Kotarski J., Meigs' syndrome with elevated ca-125 and he-4: a case of luteinized Fibrothecoma, Prz Menopauzalny, 14, pp. 152-154, (2015)
[7]  
Yuan L., Cui L., Wang J., Gong L., A case report of Meigs' syndrome caused by ovarian Fibrothecoma with high levels of Ca125, Int J Women's Health, 16, pp. 519-525, (2024)
[8]  
Porcel J.M., Diaz J.P., Chi D.S., Clinical implications of pleural effusions in ovarian Cancer, Respirology, 17, pp. 1060-1067, (2012)
[9]  
Iavarone I., Padovano M., Pasanisi F., Della Corte L., La Mantia E., Ronsini C., Meigs syndrome and elevated ca-125: case report and literature review of an unusual presentation mimicking ovarian Cancer, Medicina, 59, (2023)
[10]  
Dochez V., Caillon H., Vaucel E., Dimet J., Winer N., Ducarme G., Biomarkers and algorithms for diagnosis of ovarian Cancer: Ca125, He4, Rmi and Roma, a review, J Ovarian Res, 12, (2019)